Topiramate Adjunctive Therapy for Partial Seizures

J Gordon Millichap

doi:10.15844/pedneurbriefs-13-5-3

Topiramate Adjunctive Therapy for Partial Seizures

Pediatric Neurology Briefs

Volume 13 (1999): Issue 5

By: J Gordon Millichap

Open Access

|May 1999

Abstract

The efficacy and safety of topiramate (TPM) (6 mg/kg/day) in children age 2 to 16 years, as adjunctive therapy for uncontrolled partial-onset seizures (75% complex partial), with or without secondarily generalized seizures, were evaluated in a multicenter, randomized, double-blind, placebo-controlled trial, organized by the Topiramate YP Study Group.

References

Elterman RD Glauser TA Wyllie A Reife R Wu SC Pledger G A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children Neurology 1999 Apr 22 52 7 1338 1344 10.1212/WNL.52.7.1338 10227615
Open DOI Search in Google Scholar Back to article
Biton V Montouris GD Ritter F Riviello JJ Reife R Lim P A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures Neurology 1999 Apr 22 52 7 1330 1337 10.1212/WNL.52.7.1330 10227614
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-13-5-3 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 34 - 35

Published on: May 1, 1999

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Topiramate,

Adjunctive Therapy,

Partial-Onset Seizures

© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 13 (1999): Issue 5